Q6RUF5 AF NFT

Blood-group-substance endo-1,4-beta-galactosidase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiha5bvxipdwg357xh7bd6vdg77fzi2gsql47ozzw5w4mgd73r62dm/metadata.json
IPFS of structure file: 
bafybeibx4ko57tgjpsr5gg6vo5wgsf5akqd6kdnsgjorg62injwp5lhjam/AF-Q6RUF5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x81F3F163c1FaF6e4c4c9c3437AD70f2b580f2212
First NFT owner address (bech32): 
genesis1s8elzc7pltmwf3xfcdph44c09dvq7gsjljwrx6
Current NFT ID #109133 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
109133
Accession (UniProt):
Q6RUF5
Name::
Blood-group-substance endo-1,4-beta-galactosidase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM PERFRINGENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6RUF5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6RUF5|EABC_CLOPF Blood-group-substance endo-1,4-beta-galactosidase OS=Clostridium perfringens OX=1502 GN=eabC PE=1 SV=1 MGGVTMKNNLKKYIKYILSVILVFFVGVNGMEVYALEESRDVYLSDLDWLNATHGDDTKSKIVQKNHPFTPGNNNQSTKISLKMEDGSISEFEKGLGTIAGSPSTITYDISGAGVTKFFSYLGIDRSANPINEQYAKVDKIEVVVDGKVIYSTINQFPNGLTYETPAIKVDLNIPENAKRLQLKSYAGEKTWGDEVVYADAKFTAKGDFVNPNDWTPAEKRREISNEKPLLMIPLYANGSKYEKGDYAFWGDDTLVGKWKEVPDDLKPYTVIQLHPDDLPKRDGVAADFYEHMLNEAQSYVNPKTNKNEPIPIVLTVYTAGNVPGYTAAHWLTTEWIEDMYSKYSALQGVFSTENYWVWTDNVESNAAEYLKLSAKYGGYFIWSEQNNGGSIEKAFGSNGKTVFKEAVEKYWENFIFMYKNTPQAEGNDAPTSSYMTGLWLTDYAYQWGGLMDTWKWYETGKWKLFESGNIGKTQGNRQWLTEPEALLGIEAMNIYLNGGCVYNFEHPAYTYGVRNEESPLFSNVIKEFFRYVINNPSPSKNEMRAKTKSLLYGNFTQNGNGNYFVGLNTEMSQSPAYTTGRYGNIPAVPSSIERNKIESRLSGSQIKLIDMNSSELSNITNRKEYFNKLYKEEYNGNIFAQKLDNRWFIYNYKYNENINQKGSFDIANIKSEVTLEPHTYLIMEDNNQSINIKLNNYRTNKDSLWEGAKNADEAKKLPEMSKVDALNWVYDSYIKNTNNGEKRTSVIKLMNIDKAPTITNVNGIEGSYDIPTVKYNSETRSAEITIKNNGNIDFDIVIK